Panadol Osteo
Behind the counter
Upscheduling of Panadol Osteo confirmed by TGA, but change pushed back till 2020 The TGA’s Advisory Committee on Medicines Scheduling (ACMS) has confirmed its earlier decision to re-schedule modified release …
GSK in the clear
Panadol Osteo pricing statement ambiguous, but not false or misleading: ACCC The Australian Competition and Consumer Commission has concluded its investigation into whether GlaxoSmithKline (GSK) made misleading statements about a …
Panadol Osteo, admit it was a mistake: Guild
It is time the government ‘fessed up’ that Panadol Osteo has been de-listed from the PBS by mistake, says the Guild today. It says that in April last year PBAC set very clear criteria …
Panadol Osteo referral: a first for the Minister
It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for …
PBS changes hurt the most needy: Guild
The Guild says patients should talk to pharmacy staff about PBS pricing changes which came into place on 1 January as it claims they may cause significant confusion among those patients most …
Panadol Osteo could double in price: Quilty
Panadol Osteo could double in price due to regulatory changes, claims the Guild’s head. Speaking on national radio, David Quilty did not hold back on his feelings and explained his concerns, especially …
PBS listings need review: Guild
An urgent review is needed of the de-listing of some medicines which were available on the PBS and now will cost more OTC, says the Guild.The Guild has written to the Pharmaceutical Benefits …